Hepatitis B core antigen expression in liver predicts HBeAg seroconversion in HBeAg positive chronic hepatitis B with pegylated interferon α-2a therapy Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- October 2013
has subject area
- 1101 Medical Biochemistry and Metabolomics (FoR)
- 1103 Clinical Sciences (FoR)
- 1107 Immunology (FoR)
- Gastroenterology & Hepatology (Science Metrix)
published in
- Hepatology Journal